Relative bioavailability of microgranulated sulfadimidine in veal calves

P Anfossi1, C Montesissa, P Pezzi

  • 1Department of Public Veterinary Health and Animal Pathology, Faculty of Veterinary Medicine, University of Bologna, Ozzano Emilia (BO), Italy.

Insights

Microgranulated sulfadimidine shows poor bioavailability in milk-fed calves due to rapid gastrointestinal transit. This formulation is unsuitable for calves, though it may be effective in species with slower digestion.

Area of Science:

  • Veterinary pharmacology
  • Animal science

Background:

  • Sulfadimidine is a commonly used sulfonamide antibiotic in veterinary medicine.
  • Formulation affects drug absorption and bioavailability.

Purpose of the Study:

  • To compare the pharmacokinetics of free and microgranulated sulfadimidine in milk-fed calves.
  • To evaluate the suitability of microgranulated sulfadimidine for this animal model.

Main Methods:

  • Oral administration of sulfadimidine (180 mg/kg) in a crossover study design.
  • Comparison of plasma concentration-time profiles, including Area Under the Curve (AUC) and maximum plasma concentration (Cmax).

Main Results:

  • Microgranulation significantly delayed sulfadimidine absorption and reduced bioavailability.
  • AUC(0-infinity) decreased from 7400 to 3781 micrograms.h/mL.
  • Cmax reduced from 188.1 +/- 39.0 to 84.41 +/- 22.6 micrograms/mL.

Conclusions:

  • Microgranulated sulfadimidine is not suitable for milk-fed calves due to rapid gastrointestinal transit limiting drug release and bioavailability.
  • This formulation might be more effective in animal species with slower gastrointestinal transit times.

Related Concept Videos

Bioavailability: Overview01:13

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...